For the first time, patients with the deadliest form of skin cancer have two new treatment options that prolong survival, according to new research presented at a cancer conference in Chicago on Sunday.
One drug specifically targets a mutated gene that tells a cancer cell to grow, the other boosts a patient’s immune system in the fight against the disease. Both drugs cause tumors to shrink and prolong survival for patients with melanoma that has spread to other parts of the body.




























